Separation, characterization, and quantification of atorvastatin and related impurities by liquid chromatography-electrospray ionization mass spectrometry

Analytical Letters

Volumn 43, Issue 18, 2010, Pages 2859-2871

  Mornar, A ^a   Damic M ^a   Nigovic B ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Atorvastatin; Electrospray ionization; Pharmaceuticals; Related impurities; Tandem mass spectrometry

Indexed keywords

EID: 78650193246     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032711003763624     Document Type: Article

References (18)

1. Altuntas, T. G., and N. Erk. 2004. Liquid chromatographic determination of atorvastatin in bulk drug, tablets, and human plasma. J. Liq. Chromatogr. Relat. Technol. 27: 83-93.
2. Chaudhari, B. G., N. M. Patel, and P. B. Shah. 2007. Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products. Chem. Pharm. Bull. 55: 241-246.
3. Erturk, S., E. S. Aktas, L. Ersoy, and S. Ficicioglu. 2003. An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets. J. Pharm. Biomed. Anal. 33: 1017-1023.
4. Erturk, S., A. Onal, and S. M. Cetin. 2003. Analytical methods for the quantitative determination of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in biological samples. J. Chromatogr. B. 793: 193-205.
5. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2006. Topic Q3A(R2), Impurities in new drug substances. ICH harmonised tripartite guideline, Current version approved 25 October 2006.
6. Kadav, A. A., and D. N. Vora. 2008. Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets. J. Pharm. Biomed. Anal. 48: 120-126.
7. Kearney, S., L. F. Crawford, S. C. Mehta, and G. W. Radebaugh. 1993. Interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxy-acid forms of the HMG-CoA reductase inhibitor. Pharm. Res. 10: 1461-1465.
8. Mc Taggart, F., and P. Jones. 2008. Effects of statins on high-density lipoproteins: A potential contribution to cardiovascular benefit. Cardiovasc. Drugs Ther. 22: 321-338.
9. Miao, X.-S., and C. D. Metcalfe. 2003. Determination of pharmaceuticals in aqueous samples using positive and negative voltage switching microbore liquid chromatography/ electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 38: 27-34.
10. Miller, J. M., A. C. Blackburn, Y. Shi, A. J. Melzak, and H. Y. Ando. 2002. Semi-empirical relationships between effective mobility, charge, and molecular weight of pharmaceuticals by pressure-assisted capillary electrophoresis: Applications in drug discovery. Electro- phoresis. 23: 2833-2841.
11. Mohammadi, A., N. Rezanour, M. A. Dogaheh, F. G. Bidkorbeh, M. Hashem, and R. B. Walker. 2007. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. J. Chromatogr. B. 846: 215-221.
12. Nigovic, B., M. Damic, R. Injac, N. Kocevar Glavac, and B. Strukelj. 2009. Analysis of atorvastatin and related substances by MEKC. Chromatographia. 69: 1299-1305.
13. Nirogi, R., K. Mudigonda, and V. Kandikere. 2007. Chromatography-mass spectrometry methods for the quantification of statins in biological samples. J. Pharm. Biomed. Anal. 44: 379-387.
14. Novakova, L., D. Satinsky, and P. Solich. 2008. HPLC methods for the determination of simvastatin and atorvastatin. TrAC Trends Anal. Chem. 27: 352-367.
15. Pasha, M. K., S. Muzeeb, S. J. S. Basha, D. Shashikumar, R. Mullangi, and N. R. Srinivas. 2006. Analysis of five HMG-CoA reductase inhibitors - atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: Pharmacological, pharmacokinetic and analytical over-view and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies. Biomed. Chromatogr. 20: 282-293.
16. Petkovska, R., C. Cornett, and A. Dimitrovska. 2008. Development and validation of rapid resolution RP-HPLC method for simultaneous determination of atorvastatin and related compounds by use of chemometrics. Anal. Lett. 41: 992-1009.
17. Seshachalam, U., and C. B. Kothapally. 2008. HPLC analysis for simultaneous determination of atorvastatin and ezetimibe in pharmaceutical formulations. J. Liq. Chromatogr. Relat. Technol. 31: 714-721.
18. Shaha, R. P., V. Kumar, and S. Singh. 2008. Liquid chromatography/mass spectrometric studies on atorvastatin and its stress degradation products. Rapid Commun. Mass Spectrom. 22: 613-622.